Skip to content

Pilot Study Comparing Taliderm™ Dressing Versus Standard of Care for Open Incision and Drainage of Wounds

Pilot Study Comparing Taliderm™ Dressing Versus Standard of Care for Open Incision and Drainage of Wounds

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00686296
Enrollment
56
Registered
2008-05-29
Start date
2008-12-31
Completion date
2011-04-30
Last updated
2015-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wounds

Keywords

soft tissue abscess requiring incision and drainage

Brief summary

To evaluate wound healing with the use of Taliderm™ dressing and compare it to wet to dry dressing in the treatment of open wounds after incision and drainage.

Interventions

OTHERTaliderm™

taliderm™ dressing application once

OTHERstandard wet to dry dressing with gauze

wet to dry dressing standard of care

Sponsors

The University of Texas Health Science Center at San Antonio
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Inpatients with soft tissue abscess that will result in an open surgical wounds greater than or equal to 4 cms in any dimension * Wound will require serial dressing changes * Greater than or equal to 18 years of age * Ability to obtain informed consent

Exclusion criteria

* Inability to obtain informed consent * Pregnancy * Prisoner

Design outcomes

Primary

MeasureTime frame
The primary endpoint of this study will be rate of wound healing (judged as per cent complete wound closure) at the two (2) and three (3) week follow-up visits.two and three weeks

Secondary

MeasureTime frame
occurence of wound infectiontwo and three weeks

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026